Complementary Feeding for Infant Growth and Gut Health
(MINT Trial)
Trial Summary
What is the purpose of this trial?
This study plans to learn more about how consuming different foods during the time of early complementary feeding (\~5 to 12 months) affects growth and the development of bacteria living inside your baby's gut through school-age. The results from this study will potentially help to support future recommendations and dietary guidance for infant feeding practices.The three primary aims include:Aim 1. Identify the impact of dietary patterns with different protein-rich foods on infant growth.Aim 2. Identify the impact of dietary patterns with different protein-rich foods on infant gut microbiota development.Aim 3. Identify gut microbial taxa and genes that affect infant growth.
Eligibility Criteria
This trial is for full-term, healthy infants with no prior complementary food exposure or antibiotics use from birth to 5 months. Eligible babies must be able to eat the study foods and come from a single birth delivered vaginally.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive complementary foods with different protein-rich foods to study their effects on growth and gut microbiota development
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Complementary Feeding
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator